RUNX1 and pulmonary arterial hypertension: By examining the role of SOX17 and RUNX1 in the pathogenesis of PAH we hope to further our understanding of the cellular mechanisms that drive remodeling of damaged lung vessels in pulmonary vascular disease and propose potential future therapeutic targets for the treatment of patients with PAH.